Michel D - Search Results

1

Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.

Singh J, Yang P, Michel D, Verrall RE, Foldvari M, Badea I. Singh J, et al. Among authors: michel d. Curr Drug Deliv. 2011 May;8(3):299-306. doi: 10.2174/156720111795256200. Curr Drug Deliv. 2011. PMID: 21291379

2

Evidence for lymphatic transport of insulin by topically applied biphasic vesicles.

King MJ, Michel D, Foldvari M. King MJ, et al. Among authors: michel d. J Pharm Pharmacol. 2003 Oct;55(10):1339-44. doi: 10.1211/0022357021918. J Pharm Pharmacol. 2003. PMID: 14607014

3

Gene delivery into human skin in vitro using biphasic lipid vesicles.

Foldvari M, Kumar P, King M, Batta R, Michel D, Badea I, Wloch M. Foldvari M, et al. Among authors: michel d. Curr Drug Deliv. 2006 Jan;3(1):89-93. doi: 10.2174/156720106775197501. Curr Drug Deliv. 2006. PMID: 16472098

4

Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.

Singh J, Michel D, Chitanda JM, Verrall RE, Badea I. Singh J, et al. Among authors: michel d. J Nanobiotechnology. 2012 Feb 1;10:7. doi: 10.1186/1477-3155-10-7. J Nanobiotechnology. 2012. PMID: 22296763 Free PMC article.

5

Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma.

Michel D, Chitanda JM, Balogh R, Yang P, Singh J, Das U, El-Aneed A, Dimmock J, Verrall R, Badea I. Michel D, et al. Eur J Pharm Biopharm. 2012 Aug;81(3):548-56. doi: 10.1016/j.ejpb.2012.03.016. Epub 2012 Apr 17. Eur J Pharm Biopharm. 2012. PMID: 22531300

6

Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies.

Kaur R, Chitanda JM, Michel D, Maley J, Borondics F, Yang P, Verrall RE, Badea I. Kaur R, et al. Among authors: michel d. Int J Nanomedicine. 2012;7:3851-66. doi: 10.2147/IJN.S32877. Epub 2012 Jul 19. Int J Nanomedicine. 2012. PMID: 22904623 Free PMC article.

7

Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.

Mohammed-Saeid W, Michel D, El-Aneed A, Verrall RE, Low NH, Badea I. Mohammed-Saeid W, et al. Among authors: michel d. J Pharm Pharm Sci. 2012;15(4):548-67. doi: 10.18433/j3x60d. J Pharm Pharm Sci. 2012. PMID: 23106958 Free article.

8

In vivo sustained dermal delivery and pharmacokinetics of interferon alpha in biphasic vesicles after topical application.

King M, Kumar P, Michel D, Batta R, Foldvari M. King M, et al. Among authors: michel d. Eur J Pharm Biopharm. 2013 Aug;84(3):532-9. doi: 10.1016/j.ejpb.2013.01.014. Epub 2013 Mar 14. Eur J Pharm Biopharm. 2013. PMID: 23500117

9

Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.

Poorghorban M, Das U, Alaidi O, Chitanda JM, Michel D, Dimmock J, Verrall R, Grochulski P, Badea I. Poorghorban M, et al. Among authors: michel d. Int J Nanomedicine. 2015 Jan 12;10:503-15. doi: 10.2147/IJN.S70828. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25609956 Free PMC article.

10

Development of amino acid substituted gemini surfactant-based mucoadhesive gene delivery systems for potential use as noninvasive vaginal genetic vaccination.

Singh J, Michel D, Getson HM, Chitanda JM, Verrall RE, Badea I. Singh J, et al. Among authors: michel d. Nanomedicine (Lond). 2015 Feb;10(3):405-17. doi: 10.2217/nnm.14.123. Nanomedicine (Lond). 2015. PMID: 25707975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

702 results

Search Page

Filters